- Previous Close
114.85 - Open
116.00 - Bid 114.74 x 40000
- Ask 115.99 x 45100
- Day's Range
114.54 - 119.83 - 52 Week Range
108.12 - 148.27 - Volume
6,576 - Avg. Volume
33,084 - Market Cap (intraday)
40.013B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
29.21 - EPS (TTM)
3.96 - Earnings Date May 12, 2025 - May 18, 2025
- Forward Dividend & Yield 0.71 (0.62%)
- Ex-Dividend Date Sep 30, 2024
- 1y Target Est
149.33
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it engages in the research, development, manufacture, and sale of photomasks for manufacturing flat panel displays. Additionally, the company offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke, a time and attendance management service, as well as Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.
www.hoya.comRecent News: HOCPY
View MorePerformance Overview: HOCPY
Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HOCPY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HOCPY
View MoreValuation Measures
Market Cap
40.01B
Enterprise Value
36.38B
Trailing P/E
29.28
Forward P/E
25.19
PEG Ratio (5yr expected)
2.26
Price/Sales (ttm)
6.99
Price/Book (mrq)
5.89
Enterprise Value/Revenue
6.31
Enterprise Value/EBITDA
17.52
Financial Highlights
Profitability and Income Statement
Profit Margin
24.80%
Return on Assets (ttm)
12.35%
Return on Equity (ttm)
22.04%
Revenue (ttm)
837.43B
Net Income Avi to Common (ttm)
207.66B
Diluted EPS (ttm)
3.96
Balance Sheet and Cash Flow
Total Cash (mrq)
579.28B
Total Debt/Equity (mrq)
3.51%
Levered Free Cash Flow (ttm)
138.05B